First Tracks reports positive Phase 1b celiac data, plans late-stage trial in 2027Nov 3Quarterly updateFirst Tracks Biotherapeutics, Inc.
Kiniksa raises 2026 ARCALYST sales guidance, confirms KPL-387 data timingOct 27Regulatory decisionAlvotechFirst Tracks Biotherapeutics, Inc.Updated
First Tracks Biotherapeutics closes $200 million private placementOct 20FinancingFirst Tracks Biotherapeutics, Inc.Updated
First Tracks reports Q2 2026 results, ANB033 gets FDA Fast Track in celiac diseaseAug 12Quarterly updateFirst Tracks Biotherapeutics, Inc.